Table 2.
SF-36 scores of short-term survivors at baseline and 4-month follow-up
| Baseline | 4-month Follow-up | p Valuea | |
|---|---|---|---|
| Scale | Mean (SD) | Mean (SD) | |
| PF | 63.1 (28.6) | 53.9 (32.4) | NS |
| RP | 14.1 (24.1) | 21.7 (38.8) | NS |
| BP | 65.4 (28.9) | 78.6 (20.4) | NS |
| GH | 56.5 (19.2) | 39.7 (17.2) | 0.015 |
| VT | 59.0 (20.0) | 47.8 (21.9) | NS |
| SF | 67.2 (25.0) | 70.0 (31.6) | NS |
| RE | 48.9 (45.2) | 42.2 (42.7) | NS |
| MH | 67.8 (19.4) | 63.5 (21.5) | NS |
Abbreviations: SF-36, Medical Outcomes Study Short Form 36; PF, physical functioning; NS, not significant; RP, role physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role emotional; MH, mental health.
a
Nonparametric (Wilcoxon).